{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:19:38Z","timestamp":1744258778176,"version":"3.40.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,9]]},"DOI":"10.7759\/cureus.81958","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:07:06Z","timestamp":1744207626000},"source":"Crossref","is-referenced-by-count":0,"title":["Congestive Heart Failure and Arrhythmias Among Hospitalized Patients With Carcinoid Syndrome"],"prefix":"10.7759","author":[{"given":"Etuk","family":"Aniekeme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demilade","family":"Soji-Ayoade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Komal","family":"Sodhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Rueda Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09624-y","article-title":"Update in carcinoid heart disease - the heart of the matter","volume":"22","author":"Oleinikov K","year":"2021","unstructured":"Oleinikov K, Korach A, Planer D, Gilon D, Grozinsky-Glasberg S. Update in carcinoid heart disease - the heart of the matter. Rev Endocr Metab Disord. 2021, 22:553-61. 10.1007\/s11154-020-09624-y","journal-title":"Rev Endocr Metab Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30110-9","article-title":"Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study","volume":"18","author":"Halperin DM","year":"2017","unstructured":"Halperin DM, Shen C, Dasari A, et al.. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study. Lancet Oncol. 2017, 18:525-34. 10.1016\/S1470-2045(17)30110-9","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09547-8","article-title":"Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications","volume":"21","author":"Fanciulli G","year":"2020","unstructured":"Fanciulli G, Ruggeri RM, Grossrubatscher E, et al.. Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications. Rev Endocr Metab Disord. 2020, 21:599-612. 10.1007\/s11154-020-09547-8","journal-title":"Rev Endocr Metab Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000382053","article-title":"Clinical syndromes related to gastrointestinal neuroendocrine neoplasms","volume":"44","author":"Boutzios G","year":"2015","unstructured":"Boutzios G, Kaltsas G. Clinical syndromes related to gastrointestinal neuroendocrine neoplasms. Front Horm Res. 2015, 44:40-57. 10.1159\/000382053","journal-title":"Front Horm Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31079","article-title":"Neuroendocrine tumors and fibrosis: An unsolved mystery?","volume":"123","author":"Laskaratos FM","year":"2017","unstructured":"Laskaratos FM, Rombouts K, Caplin M, Toumpanakis C, Thirlwell C, Mandair D. Neuroendocrine tumors and fibrosis: An unsolved mystery?. Cancer. 2017, 123:4770-90. 10.1002\/cncr.31079","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/335254a0","article-title":"Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HT1B receptors coupled to a Gi-protein","volume":"335","author":"Seuwen K","year":"1988","unstructured":"Seuwen K, Magnaldo I, Pouyss\u00e9gur J. Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HT1B receptors coupled to a Gi-protein. Nature. 1988, 335:254-6. 10.1038\/335254a0","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.1994.266.1.L46","article-title":"Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture","volume":"266","author":"Lee SL","year":"1994","unstructured":"Lee SL, Wang WW, Lanzillo JJ, Fanburg BL. Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. Am J Physiol. 1994, 266:L46-52. 10.1152\/ajplung.1994.266.1.L46","journal-title":"Am J Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000159356.42064.48","article-title":"Long-term serotonin administration induces heart valve disease in rats","volume":"111","author":"Gustafsson BI","year":"2005","unstructured":"Gustafsson BI, T\u00f8mmer\u00e5s K, Nordrum I, et al.. Long-term serotonin administration induces heart valve disease in rats. Circulation. 2005, 111:1517-22. 10.1161\/01.CIR.0000159356.42064.48","journal-title":"Circulation"},{"key":"ref9","article-title":"Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease","volume":"142","author":"Waltenberger J","year":"1993","unstructured":"Waltenberger J, Lundin L, Oberg K, Wilander E, Miyazono K, Heldin CH, Funa K. Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol. 1993, 142:71-8.","journal-title":"Am J Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036043","article-title":"Molecular biology of carcinoid heart disease: Seeking therapeutic targets in the era of targeted therapy","volume":"102","author":"Khan SA","year":"2023","unstructured":"Khan SA, Devkota D, Chaudhary RK, Luitel A, Parajuli SB, Bista M, Rayamajhi A. Molecular biology of carcinoid heart disease: Seeking therapeutic targets in the era of targeted therapy. Medicine (Baltimore). 2023, 102:e36043. 10.1097\/MD.0000000000036043","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad126","article-title":"Carcinoid heart disease management: a multi-disciplinary collaboration","volume":"28","author":"Das S","year":"2023","unstructured":"Das S, Stockton SS, Hassan SA. Carcinoid heart disease management: a multi-disciplinary collaboration. Oncologist. 2023, 28:575-83. 10.1093\/oncolo\/oyad126","journal-title":"Oncologist"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000507847","article-title":"Carcinoid heart disease: Pathophysiology, pathology, clinical manifestations, and management","volume":"146","author":"Jin C","year":"2021","unstructured":"Jin C, Sharma AN, Thevakumar B, et al.. Carcinoid heart disease: Pathophysiology, pathology, clinical manifestations, and management. Cardiology. 2021, 146:65-73. 10.1159\/000507847","journal-title":"Cardiology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00904","article-title":"New insights in cardiac \u03b2-adrenergic signaling during heart failure and aging","volume":"9","author":"de Lucia C","year":"2018","unstructured":"de Lucia C, Eguchi A, Koch WJ. New insights in cardiac \u03b2-adrenergic signaling during heart failure and aging. Front Pharmacol. 2018, 9:904. 10.3389\/fphar.2018.00904","journal-title":"Front Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000081520.25714.D9","article-title":"Functional consequence of serotonin\/5-HT2B receptor signaling in heart: role of mitochondria in transition between hypertrophy and heart failure?","volume":"108","author":"Nebigil CG","year":"2003","unstructured":"Nebigil CG, Maroteaux L. Functional consequence of serotonin\/5-HT2B receptor signaling in heart: role of mitochondria in transition between hypertrophy and heart failure?. Circulation. 2003, 108:902-8. 10.1161\/01.CIR.0000081520.25714.D9","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054765","article-title":"Cardiac roles of serotonin (5-HT) and 5-HT-receptors in health and disease","volume":"24","author":"Neumann J","year":"2023","unstructured":"Neumann J, Hofmann B, Dhein S, Gergs U. Cardiac roles of serotonin (5-HT) and 5-HT-receptors in health and disease. Int J Mol Sci. 2023, 24:4765. 10.3390\/ijms24054765","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2023.03.014","article-title":"Impact of atrial fibrillation on patients with carcinoid syndrome: a National Inpatient Sample analysis","volume":"196","author":"Babbili A","year":"2023","unstructured":"Babbili A, Thotamgari SR, Thakre A, Patel S, Grewal US, Dominic P. Impact of atrial fibrillation on patients with carcinoid syndrome: a National Inpatient Sample analysis. Am J Cardiol. 2023, 196:67-9. 10.1016\/j.amjcard.2023.03.014","journal-title":"Am J Cardiol"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1046\/j.1540-8167.2003.02381.x","article-title":"5-hydroxytryptamine and atrial fibrillation: how significant is this piece in the puzzle?","volume":"14","author":"Yusuf S","year":"2003","unstructured":"Yusuf S, Al-Saady N, Camm AJ. 5-hydroxytryptamine and atrial fibrillation: how significant is this piece in the puzzle?. J Cardiovasc Electrophysiol. 2003, 14:209-14.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2006.08.007","article-title":"Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation","volume":"42","author":"Pau D","year":"2007","unstructured":"Pau D, Workman AJ, Kane KA, Rankin AC. Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation. J Mol Cell Cardiol. 2007, 42:54-62. 10.1016\/j.yjmcc.2006.08.007","journal-title":"J Mol Cell Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(94)90058-2","article-title":"Do human atrial 5-HT4 receptors mediate arrhythmias?","volume":"15","author":"Kaumann","year":"1994","unstructured":"Kaumann, AJ. Do human atrial 5-HT4 receptors mediate arrhythmias?. Trends Pharmacol Sci. 1994, 15:451-5. 10.1016\/0165-6147(94)90058-2","journal-title":"Trends Pharmacol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2005.12.004","article-title":"5-hydroxytryptamine receptors in the human cardiovascular system","volume":"111","author":"Kaumann AJ","year":"2006","unstructured":"Kaumann AJ, Levy FO. 5-hydroxytryptamine receptors in the human cardiovascular system. Pharmacol Ther. 2006, 111:674-706. 10.1016\/j.pharmthera.2005.12.004","journal-title":"Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.593459","article-title":"Serotonin transporter mechanisms and cardiac disease","volume":"113","author":"Levy RJ","year":"2006","unstructured":"Levy RJ. Serotonin transporter mechanisms and cardiac disease. Circulation. 2006, 113:2-4. 10.1161\/CIRCULATIONAHA.105.593459","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28946","article-title":"The risk of fatal arrhythmias associated with sertraline in patients with post-myocardial infarction depression","volume":"14","author":"Gutlapalli SD","year":"2022","unstructured":"Gutlapalli SD, Prakash K, Swarnakari KM, et al.. The risk of fatal arrhythmias associated with sertraline in patients with post-myocardial infarction depression. Cureus. 2022, 14:e28946. 10.7759\/cureus.28946","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2016.08.002","article-title":"Cardiovascular remodeling and the peripheral serotonergic system","volume":"110","author":"Ayme-Dietrich E","year":"2017","unstructured":"Ayme-Dietrich E, Aubertin-Kirch G, Maroteaux L, Monassier L. Cardiovascular remodeling and the peripheral serotonergic system. Arch Cardiovasc Dis. 2017, 110:51-9. 10.1016\/j.acvd.2016.08.002","journal-title":"Arch Cardiovasc Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.1041940","article-title":"ER stress and calcium-dependent arrhythmias","volume":"13","author":"Hamilton S","year":"2022","unstructured":"Hamilton S, Terentyev D. ER stress and calcium-dependent arrhythmias. Front Physiol. 2022, 13:1041940. 10.3389\/fphys.2022.1041940","journal-title":"Front Physiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1324132111","article-title":"Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation","volume":"111","author":"Christ T","year":"2014","unstructured":"Christ T, Rozmaritsa N, Engel A, et al.. Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation. Proc Natl Acad Sci U S A. 2014, 111:11193-8. 10.1073\/pnas.1324132111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2014.12.015","article-title":"Atrial remodeling, fibrosis, and atrial fibrillation","volume":"25","author":"Jalife J","year":"2015","unstructured":"Jalife J, Kaur K. Atrial remodeling, fibrosis, and atrial fibrillation. Trends Cardiovasc Med. 2015, 25:475-84. 10.1016\/j.tcm.2014.12.015","journal-title":"Trends Cardiovasc Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00337.2014","article-title":"Chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression","volume":"309","author":"Matchkov VV","year":"2015","unstructured":"Matchkov VV, Kravtsova VV, Wiborg O, Aalkjaer C, Bouzinova EV. Chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression. Am J Physiol Regul Integr Comp Physiol. 2015, 309:R814-23. 10.1152\/ajpregu.00337.2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.528133","article-title":"Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury","volume":"112","author":"Bianchi P","year":"2005","unstructured":"Bianchi P, Kunduzova O, Masini E, et al.. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation. 2005, 112:3297-305. 10.1161\/CIRCULATIONAHA.104.528133","journal-title":"Circulation"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000695","article-title":"Contribution of serotonin to cardiac remodeling associated with hypertensive diastolic ventricular dysfunction in rats","volume":"33","author":"Ayme-Dietrich E","year":"2015","unstructured":"Ayme-Dietrich E, Marzak H, Lawson R, et al.. Contribution of serotonin to cardiac remodeling associated with hypertensive diastolic ventricular dysfunction in rats. J Hypertens. 2015, 33:2310-21. 10.1097\/HJH.0000000000000695","journal-title":"J Hypertens"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13101172","article-title":"Modulatory impact of oxidative stress on action potentials in pathophysiological states: a comprehensive review","volume":"13","author":"Mahapatra C","year":"2024","unstructured":"Mahapatra C, Thakkar R, Kumar R. Modulatory impact of oxidative stress on action potentials in pathophysiological states: a comprehensive review. Antioxidants (Basel). 2024, 13:1172. 10.3390\/antiox13101172","journal-title":"Antioxidants (Basel)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.030","article-title":"Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement","volume":"69","author":"Davar J","year":"2017","unstructured":"Davar J, Connolly HM, Caplin ME, et al.. Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement. J Am Coll Cardiol. 2017, 69:1288-304. 10.1016\/j.jacc.2016.12.030","journal-title":"J Am Coll Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.79578","article-title":"Predictors of mortality in acute myocardial infarction patients with systemic lupus erythematosus","volume":"17","author":"Aniekeme E","year":"2025","unstructured":"Aniekeme E, De Souza Goncalves B, Sodhi K, Rueda Rios C, Thompson E. Predictors of mortality in acute myocardial infarction patients with systemic lupus erythematosus. Cureus. 2025, 17:e79578. 10.7759\/cureus.79578","journal-title":"Cureus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-021-01031-z","article-title":"Carcinoid heart disease: a review","volume":"23","author":"Laskaratos FM","year":"2021","unstructured":"Laskaratos FM, Davar J, Toumpanakis C. Carcinoid heart disease: a review. Curr Oncol Rep. 2021, 23:48. 10.1007\/s11912-021-01031-z","journal-title":"Curr Oncol Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.06.053","article-title":"Cardiovascular aging and heart failure: JACC Review Topic of the Week","volume":"74","author":"Triposkiadis F","year":"2019","unstructured":"Triposkiadis F, Xanthopoulos A, Butler J. Cardiovascular aging and heart failure: JACC Review Topic of the Week. J Am Coll Cardiol. 2019, 74:804-13. 10.1016\/j.jacc.2019.06.053","journal-title":"J Am Coll Cardiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2012.08.005","article-title":"Mechanisms of arrhythmias and conduction disorders in older adults","volume":"28","author":"Mirza M","year":"2012","unstructured":"Mirza M, Strunets A, Shen WK, Jahangir A. Mechanisms of arrhythmias and conduction disorders in older adults. Clin Geriatr Med. 2012, 28:555-73. 10.1016\/j.cger.2012.08.005","journal-title":"Clin Geriatr Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.06.035","article-title":"High-dose oral intake of serotonin induces valvular heart disease in rabbits","volume":"197","author":"Lancellotti P","year":"2015","unstructured":"Lancellotti P, Nchimi A, Hego A, Dulgheru R, Delvenne P, Drion P, Oury C. High-dose oral intake of serotonin induces valvular heart disease in rabbits. Int J Cardiol. 2015, 197:72-5. 10.1016\/j.ijcard.2015.06.035","journal-title":"Int J Cardiol"},{"key":"ref37","article-title":"Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents","volume":"9","author":"Hafizi S","year":"2000","unstructured":"Hafizi S, Taylor PM, Chester AH, Allen SP, Yacoub MH. Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents. J Heart Valve Dis. 2000, 9:454-8.","journal-title":"J Heart Valve Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.10.055","article-title":"Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice","volume":"226","author":"Fujisaka T","year":"2013","unstructured":"Fujisaka T, Hoshiga M, Hotchi J, et al.. Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice. Atherosclerosis. 2013, 226:82-7. 10.1016\/j.atherosclerosis.2012.10.055","journal-title":"Atherosclerosis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00029.2005","article-title":"Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy","volume":"26","author":"Hingtgen SD","year":"2006","unstructured":"Hingtgen SD, Tian X, Yang J, et al.. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol Genomics. 2006, 26:180-91. 10.1152\/physiolgenomics.00029.2005","journal-title":"Physiol Genomics"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.36628\/ijhf.2020.0004","article-title":"Sex and gender differences in heart failure","volume":"2","author":"Regitz-Zagrosek V","year":"2020","unstructured":"Regitz-Zagrosek V. Sex and gender differences in heart failure. Int J Heart Fail. 2020, 2:157-81. 10.36628\/ijhf.2020.0004","journal-title":"Int J Heart Fail"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.15420\/usc.2022.38","article-title":"Sex and gender differences in ventricular arrhythmias","volume":"17","author":"Warnock RK","year":"2023","unstructured":"Warnock RK, Modi RD, Westerman SB. Sex and gender differences in ventricular arrhythmias. US Cardiol. 2023, 17:e12. 10.15420\/usc.2022.38","journal-title":"US Cardiol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016601","article-title":"Contemporary reevaluation of race and ethnicity with outcomes in heart failure","volume":"10","author":"Savitz ST","year":"2021","unstructured":"Savitz ST, Leong T, Sung SH, Lee K, Rana JS, Tabada G, Go AS. Contemporary reevaluation of race and ethnicity with outcomes in heart failure. J Am Heart Assoc. 2021, 10:e016601. 10.1161\/JAHA.120.016601","journal-title":"J Am Heart Assoc"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59497","article-title":"Racial and socioeconomic determinants of cardiovascular health: a comprehensive review","volume":"16","author":"Borkowski P","year":"2024","unstructured":"Borkowski P, Borkowska N, Mangeshkar S, Adal BH, Singh N. Racial and socioeconomic determinants of cardiovascular health: a comprehensive review. Cureus. 2024, 16:e59497. 10.7759\/cureus.59497","journal-title":"Cureus"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.121.007917","article-title":"Race, racism, and cardiovascular health: applying a social determinants of health framework to racial\/ethnic disparities in cardiovascular disease","volume":"15","author":"Javed Z","year":"2022","unstructured":"Javed Z, Haisum Maqsood M, Yahya T, et al.. Race, racism, and cardiovascular health: applying a social determinants of health framework to racial\/ethnic disparities in cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2022, 15:e007917. 10.1161\/CIRCOUTCOMES.121.007917","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.002154","article-title":"Racial differences in arterial stiffness and microcirculatory function between Black and White Americans","volume":"2","author":"Morris AA","year":"2013","unstructured":"Morris AA, Patel RS, Binongo JN, et al.. Racial differences in arterial stiffness and microcirculatory function between Black and White Americans. J Am Heart Assoc. 2013, 2:e002154. 10.1161\/JAHA.112.002154","journal-title":"J Am Heart Assoc"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2016.10.011","article-title":"Race-Related Differences in Left\u00a0Ventricular Structural and Functional\u00a0Remodeling in Response\u00a0to\u00a0Increased Afterload: The ARIC Study","volume":"5","author":"Fernandes-Silva MM","year":"2017","unstructured":"Fernandes-Silva MM, Shah AM, Hegde S, et al.. Race-Related Differences in Left\u00a0Ventricular Structural and Functional\u00a0Remodeling in Response\u00a0to\u00a0Increased Afterload: The ARIC Study. JACC Heart Fail. 2017, 5:157-65. 10.1016\/j.jchf.2016.10.011","journal-title":"JACC Heart Fail"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2015.02.008","article-title":"Racial differences in natriuretic peptide levels: the Dallas Heart Study","volume":"3","author":"Gupta DK","year":"2015","unstructured":"Gupta DK, de Lemos JA, Ayers CR, Berry JD, Wang TJ. Racial differences in natriuretic peptide levels: the Dallas Heart Study. JACC Heart Fail. 2015, 3:513-9. 10.1016\/j.jchf.2015.02.008","journal-title":"JACC Heart Fail"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65949","article-title":"Enhancing heart failure diagnosis accuracy and distinguishing it from other pulmonary conditions: a retrospective case series study leveraging the HeartLogic parameters","volume":"16","author":"Zaheer K","year":"2024","unstructured":"Zaheer K, Goncalves B, Suliman M, Ramalingam A, Sodhi K, Rueda Rios C. Enhancing heart failure diagnosis accuracy and distinguishing it from other pulmonary conditions: a retrospective case series study leveraging the HeartLogic parameters. Cureus. 2024, 16:e65949. 10.7759\/cureus.65949","journal-title":"Cureus"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11112164","article-title":"Chronic kidney disease and heart failure-everyday diagnostic challenges","volume":"11","author":"Adamska-We\u0142nicka A","year":"2021","unstructured":"Adamska-We\u0142nicka A, We\u0142nicki M, Mamcarz A, Gellert R. Chronic kidney disease and heart failure-everyday diagnostic challenges. Diagnostics (Basel). 2021, 11:2164. 10.3390\/diagnostics11112164","journal-title":"Diagnostics (Basel)"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski J","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021, 143:1157-72. 10.1161\/CIRCULATIONAHA.120.050686","journal-title":"Circulation"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-016-0287-0","article-title":"Cardiac autonomic function in patients with acute exacerbation of chronic obstructive pulmonary disease with and without ventricular tachycardia","volume":"16","author":"Wang X","year":"2016","unstructured":"Wang X, Jiang Z, Chen B, et al.. Cardiac autonomic function in patients with acute exacerbation of chronic obstructive pulmonary disease with and without ventricular tachycardia. BMC Pulm Med. 2016, 16:124. 10.1186\/s12890-016-0287-0","journal-title":"BMC Pulm Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1177\/2045894020910685","article-title":"Atrial arrhythmias in chronic lung disease-associated pulmonary hypertension","volume":"10","author":"Vahdatpour CA","year":"2020","unstructured":"Vahdatpour CA, Luebbert JJ, Palevsky HI. Atrial arrhythmias in chronic lung disease-associated pulmonary hypertension. Pulm Circ. 2020, 10:2045894020910685. 10.1177\/2045894020910685","journal-title":"Pulm Circ"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2022.01.026","article-title":"Inflammation as a mechanism and therapeutic target in peripheral artery disease","volume":"38","author":"Chan NC","year":"2022","unstructured":"Chan NC, Xu K, de Vries TA, Eikelboom JW, Hirsh J. Inflammation as a mechanism and therapeutic target in peripheral artery disease. Can J Cardiol. 2022, 38:588-600. 10.1016\/j.cjca.2022.01.026","journal-title":"Can J Cardiol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00885.2013","article-title":"Physiology in medicine: peripheral arterial disease","volume":"115","author":"Muller MD","year":"2013","unstructured":"Muller MD, Reed AB, Leuenberger UA, Sinoway LI. Physiology in medicine: peripheral arterial disease. J Appl Physiol (1985). 2013, 115:1219-26. 10.1152\/japplphysiol.00885.2013","journal-title":"J Appl Physiol (1985)"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.1172","article-title":"Understanding limitations of the National Inpatient Sample to facilitate its proper use","volume":"154","author":"Mori M","year":"2019","unstructured":"Mori M, Brown KJ, Geirsson A. Understanding limitations of the National Inpatient Sample to facilitate its proper use. JAMA Surg. 2019, 154:881-2. 10.1001\/jamasurg.2019.1172","journal-title":"JAMA Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348860-congestive-heart-failure-and-arrhythmias-among-hospitalized-patients-with-carcinoid-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:07:07Z","timestamp":1744207627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348860-congestive-heart-failure-and-arrhythmias-among-hospitalized-patients-with-carcinoid-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":55,"URL":"https:\/\/doi.org\/10.7759\/cureus.81958","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,9]]}}}